Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
ELC-301
Tag: ELC-301
Elicera’s CEO: “TO2 is a highly attractive opportunity to increase ownership...
3 March, 2025
Elicera Therapeutics receives partial payment of 0,5 MEur from EIC
12 February, 2025
Elicera’s CEO: ”2025 is a crucial year for us”
5 February, 2025
Elicera’s CEO: “All signs of the disease disappeared in the first...
28 January, 2025
Elicera’s CEO: “One of the biggest milestones in our history”
12 November, 2024
Elicera’s first clinical CAR T-Cell study CARMA set to begin
29 May, 2024
Full speed ahead for Elicera in 2024
19 February, 2024
Elicera’s CEO: ” iTANK has great potential in treating solid tumours”
16 November, 2023
Elicera Therapeutics receives important EU patent
13 July, 2023
Elicera gives an update in Cancer Immunotherapy Month
30 June, 2023
1
2
3
Page 1 of 3